Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Arthur J. Gallagher Targets 6% Q3 Organic Growth as Risk Management Acceleratesmarketbeat.com
Arthur J. Gallagher & Co. (NYSE:AJG) said its diversified brokerage, benefits, reinsurance and claims-management operations continue to support growth despite easing property insurance pricing, with the company projecting approximately 6% organic growth in the third quarter. Chairman and Chief
Via MarketBeat · September 25, 2026
Meta Has Lost More Than $85 Billion on Its Glasses and Headsets. Here's What Would Stop It.fool.com
What would it take to stop the losses in the social media giant's hardware unit?
Via The Motley Fool · September 25, 2026
Nike and McDonald's Are the Worst-Performing Dow Stocks This Year. Here's the 1 to Buy in October.fool.com
The brands share a similar association as titans of American export culture, and the two stocks are struggling now.
Via The Motley Fool · September 25, 2026
Matterport Virtual Tour: A More Immersive Way to Showcase Propertiestalkmarkets.com
Today, people often research a property online before they ever arrange a viewing. High-quality photography can capture attention, but static images only s
Via Talk Markets · September 25, 2026
House Painting Services for Beautiful and Lasting Home Resultstalkmarkets.com
A fresh coat of paint can completely change the look and feel of a home. It can make a room feel brighter, create a warmer atmosphere, or give an older pro
Via Talk Markets · September 25, 2026
Fast Track Merger Under Section 233: Complete Guide | Chhotacfotalkmarkets.com
Corporate restructuring is increasingly being used by companies to simplify group structures, consolidate businesses, rationalise subsidiaries and align ow
Via Talk Markets · September 25, 2026
Benzene Price Chart 2026: Global Market Trends, Regional Analysis, and Forecasttalkmarkets.com
Benzene PriceThe global Benzene Price market recorded a broad-based increase during the quarter ending June 2026, with prices rising across North America,
Via Talk Markets · September 25, 2026
Ingersoll Rand Sees Broad Demand Recovery, Long-Cycle Orders Acceleratemarketbeat.com
Ingersoll Rand (NYSE:IR) executives said improving demand in short-, medium- and long-cycle businesses, combined with investments in commercial capabilities and engineered solutions, supported a more optimistic outlook for organic growth. Speaking at a Morgan Stanley conference, Chairman, President
Via MarketBeat · September 25, 2026
India Ortho-xylene Market Agrochemicals, Chemicals & Growth 2025–2030talkmarkets.com
According to TechSci Research report, the India Ortho-Xylene Market reached 520.89 thousand Metric Tonnes in 2024 and is projected to reach 621.07 thousand
Via Talk Markets · September 25, 2026
India vs. US Web App Development: Costs, Pros, Cons & What to Expect in 2026talkmarkets.com
Building a web application in 2026 can require an investment anywhere from $20,000 to $500,000+, depending on the application's complexity, features, techn
Via Talk Markets · September 25, 2026
Why Bacteriostatic Sodium Chloride Is Used in Aesthetic Medicinetalkmarkets.com
Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here .
Via Talk Markets · September 25, 2026
Smarter Self Piercing Rivet Machine Solutions for Modern Manufacturingtalkmarkets.com
A self piercing rivet machine is an advanced mechanical joining solution for manufacturers that need reliable, repeatable, and efficient assembly of modern
Via Talk Markets · September 25, 2026
Is Micron Stock Going to $1,625? 1 Wall Street Analyst Think So.fool.com
Micron still has plenty of upside potential.
Via The Motley Fool · September 24, 2026
Handheld Nutrunner Market Size, Trends and Forecast 2024-2033talkmarkets.com
The Handheld Nutrunner Market is projected to grow from USD 278.7 million in 2024 to USD 467.7 million by 2033, registering a 5.9% CAGR during the forecast
Via Talk Markets · September 25, 2026
How French Small Businesses Actually Get Fundedtalkmarkets.com
Most French small business owners think about financing in one direction: ask the bank, get turned down or accepted, move on. The actual landscape is wider
Via Talk Markets · September 25, 2026
AirPods Pro 2nd Generation Repair: Reliable Solutions for Common Problemstalkmarkets.com
If your premium earbuds are no longer performing as expected, AirPods Pro 2nd Generation Repair can help restore their sound, charging, connectivity, and e
Via Talk Markets · September 25, 2026
Portfolio Monitoring: Strengthening Credit Risk Managementtalkmarkets.com
Lending decisions do not end when a loan is approved. A borrower's financial position, business performance, ownership structure, compliance status, and le
Via Talk Markets · September 25, 2026
Is VOO or VTI the Better Long-Term Investment? Here's What History Suggests.fool.com
There's one key advantage that separates these two ETF industry heavyweights.
Via The Motley Fool · September 24, 2026
Panditji panditji: Understanding the Importance of Proper Puja Guidancetalkmarkets.com
Religious ceremonies often carry personal and family significance, so proper guidance can be helpful when preparing for them. Many people know the basic pu
Via Talk Markets · September 25, 2026
Astera Labs vs. Marvell Technology: Which Tech Stock Is a Better Buy in 2026?fool.com
Astera Labs boasts higher revenue growth, but customer concentration poses a risk. Marvell trades at lower multiples with broader diversification.
Via The Motley Fool · September 24, 2026
Why Fervo Energy Stock Is Up Todayfool.com
The geothermal pioneer achieved a major operational milestone.
Via The Motley Fool · September 24, 2026
Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platformmarketbeat.com
Arcturus Therapeutics (NASDAQ:ARCT) presented preliminary Phase II data for ARCT-810, its mRNA therapeutic candidate for ornithine transcarbamylase, or OTC, deficiency, while outlining plans to introduce a next-generation delivery platform into the program. OTC deficiency is a urea-cycle disorder i
Via MarketBeat · September 24, 2026
Prediction: The S&P 500 Finishes 2027 Above 9,000. Here's the Earnings Math.fool.com
The prediction needs no richer valuation -- just one more year of double-digit earnings growth after 2027.
Via The Motley Fool · September 24, 2026
Nova's Chief Technology Officer Dumps Nearly 4,000 Shares for $1.4 Millionfool.com
The CTO divested 15% of his direct holdings as the stock climbed 17% over the past year.
Via The Motley Fool · September 24, 2026
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?fool.com
Revolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead.
Via The Motley Fool · September 24, 2026